{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:40:08Z","timestamp":1742215208221,"version":"3.38.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1378\/chest.11-2225","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T06:46:17Z","timestamp":1325573177000},"page":"4-5","source":"Crossref","is-referenced-by-count":1,"title":["The Importance of Sex in Pulmonary Hypertension"],"prefix":"10.1016","volume":"141","author":[{"given":"Stuart","family":"Rich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1378\/chest.11-2225_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.11-0404","article-title":"Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension","volume":"141","author":"Gabler","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.11-2225_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/FJC.0b013e3181f9ea8d","article-title":"Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease","volume":"56","author":"Tofovic","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1378\/chest.11-2225_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvq408","article-title":"The serotonin transporter, gender, and 17\u03b2 oestradiol in the development of pulmonary arterial hypertension","volume":"90","author":"White","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1378\/chest.11-2225_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0090-9556(24)15230-0","article-title":"Absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan in healthy male subjects","volume":"27","author":"Weber","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1378\/chest.11-2225_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0091270004264642","article-title":"Genetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers","volume":"44","author":"Ma","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1378\/chest.11-2225_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-118-6-199303150-00006","article-title":"Influence of sex hormones on plasma endothelin levels","volume":"118","author":"Polderman","year":"1993","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1378\/chest.11-2225_bib7","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","article-title":"Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases","volume":"26","author":"Jochmann","year":"2005","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1378\/chest.11-2225_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.298.10.1209","article-title":"Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification","volume":"298","author":"Kent","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1378\/chest.11-2225_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1378\/chest.11-2225_bib10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1378\/chest.11-2225_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1378\/chest.09-2815","article-title":"Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension","volume":"138","author":"Rich","year":"2010","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:02:25Z","timestamp":1742212945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212600026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0012369212600026"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-2225","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}